Pharmafile Logo
Pharmafocus logo
Advanced Search

NovoBiome and Inserm begin collaboration into human intestinal physiology

February 22, 2022
Manufacturing and Production

NovoBiome, a drug discovery company developing breakthrough Live Biotherapeutics Products, announced that it has signed a new collaboration with the …

News

UK to offer extra COVID-19 booster for over-75s and high risk in spring

February 22, 2022
Manufacturing and Production

An additional booster dose will be offered to all adults over-75, as well as the most vulnerable over-12s, in the …

News

Apollo Therapeutics and King’s College London collaborate for translational biology and drug development

February 22, 2022
Manufacturing and Production

Apollo Therapeutics has expanded its partnerships with world-leading UK research institutions, entering into a strategic collaboration with King’s College, London. …

News

CanSinoBIO’s Convidecia approved as heterologous COVID-19 booster in China

February 21, 2022
Sales and Marketing

CanSino Biologics announced that its recombinant novel coronavirus vaccine has been approved by the Joint Prevention and Control Mechanism of …

News

FDA approval of first disease-modifying drug for treatment of rare lifelong anaemia

February 21, 2022
Sales and Marketing

Agios Pharmaceuticals has announced the FDA approval of Pyrukynd (mitapivat), for the treatment of haemolytic anaemia in adults with pyruvate …

News

‘Historic’ results for breast cancer drug and promise for broader use

February 21, 2022
Sales and Marketing

AstraZeneca has shared that its drug, Enhertu, has demonstrated meaningful survival improvements in patients with breast cancer, compared with physician’s …

News

FDA considers approving second COVID-19 booster jab

February 21, 2022
Sales and Marketing

US health regulators are looking at authorising a potential fourth dose of a COVID-19 vaccine, as reported by the Wall …

News

Study shows antibiotics affect gut microbes of newborns

February 18, 2022
Medical Communications

Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …

News

Pfizer and BioNTech Omicron vaccine delayed

February 18, 2022
Medical Communications

The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …

News

NHS bosses call for free COVID-19 tests and isolation to remain

February 18, 2022
Medical Communications

NHS bosses have called for free COVID-19 testing to remain, in spite of speculation that this could be scrapped. Boris …

News

Trial paused for respiratory virus vaccine in pregnant women

February 18, 2022
Medical Communications

GlaxoSmithKline (GSK) has hit pause on a Phase III clinical trial on safety grounds. The late-stage trial for GSK’s vaccine …

News

FDA accepts NDA for non-small cell lung cancer treatment

February 17, 2022
Business Services

Mirati Therapeutics, a clinical-stage targeted oncology company has announced that the FDA has accepted the new drug application (NDA) for …

News

England to offer COVID-19 vaccine to five to 11-year-olds

February 17, 2022
Business Services

Children aged between five and 11 in England will be offered a low-dose vaccine, according to the government. This move …

News

First Promising Innovative Medicine designation for self-administered treatment of rare disease

February 17, 2022
Business Services

UCB has announced that zilucoplan, its developmental treatment for adults with generalized myasthenia gravis (gMG) has been granted Promising Innovative …

News

Virtual drug design platform to accelerate drug discovery

February 17, 2022
Business Services

The Cambridge Crystallographic Data Centre (CCDC) announced a strategic partnership with Dassault Systemes to advance bioscience innovation with a cloud-based …

News

Invitae launches first CE-IVD cancer testing kits in Europe

February 16, 2022
Research and Development

Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …

News

AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries

February 16, 2022
Research and Development

According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …

News

Scientists possibly cure HIV in first-time breakthrough for virus

February 16, 2022
Research and Development

An American research team appear to have cured HIV in a woman for the first time, making her the third …

News

Moderna launch Omicron-specific UK vaccine study

February 16, 2022
Research and Development

Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …

News

Astellas and Seagen announce results of study into muscle-invasive bladder cancer

February 15, 2022
Medical Communications

Astellas Pharma and Seagen announced the initial results from Cohort H of their EV-103 trial. This investigated PADDCEV (enfortumab vedotin-ejfv) …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026